|
**Overview**: Male Radiology Class 2 Initial Panel**Introduction**: The Male Radiology Class 2 Initial Panel is a diagnostic tool designed for initial health screening for cabin crew using serum and radiology assessments. In India, DGCA Class 2 initial medical examination for pilots/cabin crew requires thorough baseline evaluation to ensure fitness for aviation duties, screening for cardiovascular, metabolic, renal, hepatic, and respiratory issues. High burden from incomplete initial screening in remote/low-SES applicants, limited aviation facilities, delayed detection of hypertension, dyslipidemia, anemia, or lung pathology leading to rejection or future risks. Per aviation medicine practices aligned with DGCA and ICMR occupational health guidelines, the test combines biochemistry (CBC, fasting glucose, lipid profile, creatinine, liver enzymes) with radiology (chest X-ray, ECG) over 1-2 days with high accuracy, valuable for initial certification. This diagnostic falls under occupational screening and targets male applicants for Class 2 medical, addressing accurate detection to ensure flight safety and early intervention. With elevated burden due to under-screening, the test supports public health efforts by enabling comprehensive baseline assessment and reducing aviation health risks. Its multi-modal approach ensures reliable fitness profiling.**Other Names**: Male Rad 2I Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry/radiology, compliant with 2025 standards.**Historical Milestone**: DGCA Class 2 initial standard; in India, mandatory for aviation entry.**Purpose**: The test assesses 7 parameters including CBC to guide initial health screening, detect abnormalities, inform certification.**Test Parameters**: 1. CBC, 2. Chest X-Ray, 3. ECG, 4. Fasting Glucose, 5. Lipid Profile, 6. Creatinine, 7. Liver Enzymes.**Pretest Condition**: Fasting 10-12 hours required; patients should be initial cabin crew applicants.**Specimen**: 3 mL serum in 1 SST + radiology procedures, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on prior health issues, family history.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected conditions including rejection, benefits of initial screening, and minimal discomfort from sampling/radiology.**Procedural Considerations**: The test involves biochemistry and radiology by trained personnel to ensure sterile technique, avoid artifacts, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or non-fasting can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal findings may require further evaluation for initial certification, necessitating specialist input.**Specialist Consultation**: Aviation medical examiners should be consulted for management.**Additional Supporting Tests**: Spirometry, vision/hearing for confirmation.**Test Limitations**: Initial-specific; comprehensive approach required.**References**: Indian Journal of Aerospace Medicine 2024, Occupational Studies India 2023. |
